AGILENT TECHNOLOGIES, INC: public contracts won without a rival in United States

Updated 17 October 2026 · 2024-10-03 to 2026-08-27 · all of United States

AGILENT TECHNOLOGIES, INC: public contracts won without a rival in United States: 2 uncontested awards; 67% of its awards; 1 without a competition; 1 single bid.

Assay record ASY-US-0S197X8146 · Cite as: Assay Systems, “AGILENT TECHNOLOGIES, INC: public contracts won without a rival in United States”, https://assay-systems.com/register/us/uncontested/s/agilent-technologies-inc-2/

1
2uncontested awards
67%of its awards
1without a competition
1single bid

AGILENT TECHNOLOGIES, INC won 2 of its 3 public contract awards in United States without a rival from 2024-10-03 to 2026-08-27, worth $163K: 1 without a competition and 1 after a competition that drew a single bid. 1 buyer awarded it without a rival, the largest Food and Drug Administration with 2.

An award is uncontested when the buyer had no rival offer to weigh: it was made without a competition (direct award, negotiated procedure without a call for tenders, sole-source or advance-notice contract), or a competition was held and only one bid arrived. Every count below is built award by award from the official notices. Awards to individuals are not included.

Buyers that awarded it without a rival

Food and Drug Administration2uncontested2awards$163Kvalue

Food and Drug Administration gave AGILENT TECHNOLOGIES, INC 2 awards: 1 without a competition, 1 after a competition with a single bid. First 2024-10-03, latest 2026-08-27.

Latest awards without a rival

DateBuyerHowValueStated reason
2026-08-27Food and Drug Administration
75F40126P00219
Single bid
COMPETED UNDER SAP
$175K—
2024-10-03Food and Drug Administration
HHSF222200627061P
No competition
NOT COMPETED
$-11,369ONLY ONE SOURCE-OTHER (FAR 6.302-1 OTHER)

Every uncontested award in United States · All countries

Source: USAspending.gov prime award transactions (contracts). Awards are matched to their buyer and supplier as published. Updated 17 October 2026.